CN111808877A - Production method, composition and preparation of acetaldehyde dehydrogenase - Google Patents
Production method, composition and preparation of acetaldehyde dehydrogenase Download PDFInfo
- Publication number
- CN111808877A CN111808877A CN202010925634.3A CN202010925634A CN111808877A CN 111808877 A CN111808877 A CN 111808877A CN 202010925634 A CN202010925634 A CN 202010925634A CN 111808877 A CN111808877 A CN 111808877A
- Authority
- CN
- China
- Prior art keywords
- parts
- extract
- acetaldehyde dehydrogenase
- composition
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108010081577 aldehyde dehydrogenase (NAD(P)+) Proteins 0.000 title claims abstract description 90
- 239000000203 mixture Substances 0.000 title claims abstract description 56
- 238000002360 preparation method Methods 0.000 title claims abstract description 31
- 238000004519 manufacturing process Methods 0.000 title abstract description 16
- 210000004185 liver Anatomy 0.000 claims abstract description 17
- 206010019133 Hangover Diseases 0.000 claims abstract description 7
- 239000000284 extract Substances 0.000 claims description 168
- 208000007848 Alcoholism Diseases 0.000 claims description 22
- 201000007930 alcohol dependence Diseases 0.000 claims description 22
- 244000046146 Pueraria lobata Species 0.000 claims description 21
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 21
- 239000007788 liquid Substances 0.000 claims description 18
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 16
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 16
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 15
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 15
- 241000219780 Pueraria Species 0.000 claims description 14
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 14
- 235000011477 liquorice Nutrition 0.000 claims description 14
- 235000000485 Smilax china Nutrition 0.000 claims description 12
- 244000261559 Smilax china Species 0.000 claims description 12
- 235000003205 Smilax rotundifolia Nutrition 0.000 claims description 12
- 240000009022 Smilax rotundifolia Species 0.000 claims description 12
- 235000005340 Asparagus officinalis Nutrition 0.000 claims description 9
- 244000003416 Asparagus officinalis Species 0.000 claims description 8
- 235000003889 Paeonia suffruticosa Nutrition 0.000 claims description 6
- 240000005001 Paeonia suffruticosa Species 0.000 claims description 6
- 235000002598 Inula helenium Nutrition 0.000 claims description 5
- 244000116484 Inula helenium Species 0.000 claims description 5
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 4
- 239000003963 antioxidant agent Substances 0.000 claims description 3
- 230000003078 antioxidant effect Effects 0.000 claims description 3
- 239000011230 binding agent Substances 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 239000000314 lubricant Substances 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 239000003755 preservative agent Substances 0.000 claims description 3
- 230000002335 preservative effect Effects 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 239000002562 thickening agent Substances 0.000 claims description 3
- 239000000945 filler Substances 0.000 claims description 2
- 230000002443 hepatoprotective effect Effects 0.000 claims 2
- 239000002552 dosage form Substances 0.000 claims 1
- 210000002784 stomach Anatomy 0.000 abstract description 17
- 230000035622 drinking Effects 0.000 abstract description 8
- 102000009645 Mitochondrial Aldehyde Dehydrogenase Human genes 0.000 abstract description 7
- 108010009513 Mitochondrial Aldehyde Dehydrogenase Proteins 0.000 abstract description 7
- 238000000855 fermentation Methods 0.000 abstract description 6
- 230000004151 fermentation Effects 0.000 abstract description 6
- 241000894006 Bacteria Species 0.000 abstract description 4
- 241000588724 Escherichia coli Species 0.000 abstract description 4
- 238000002525 ultrasonication Methods 0.000 abstract description 4
- 239000001963 growth medium Substances 0.000 abstract description 3
- 238000011161 development Methods 0.000 abstract description 2
- 210000000936 intestine Anatomy 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 40
- 239000003814 drug Substances 0.000 description 38
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 23
- 239000000463 material Substances 0.000 description 20
- 210000000952 spleen Anatomy 0.000 description 20
- 230000014509 gene expression Effects 0.000 description 18
- 229940079593 drug Drugs 0.000 description 17
- 230000001737 promoting effect Effects 0.000 description 16
- 208000011580 syndromic disease Diseases 0.000 description 16
- 241000699670 Mus sp. Species 0.000 description 15
- 108090000623 proteins and genes Proteins 0.000 description 14
- 102000004169 proteins and genes Human genes 0.000 description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- 235000008216 herbs Nutrition 0.000 description 12
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 12
- 206010012735 Diarrhoea Diseases 0.000 description 10
- 230000003472 neutralizing effect Effects 0.000 description 10
- 206010011224 Cough Diseases 0.000 description 8
- 206010062717 Increased upper airway secretion Diseases 0.000 description 8
- 208000004880 Polyuria Diseases 0.000 description 8
- 230000007812 deficiency Effects 0.000 description 8
- 230000035619 diuresis Effects 0.000 description 8
- 230000001939 inductive effect Effects 0.000 description 8
- 210000004072 lung Anatomy 0.000 description 8
- 208000026435 phlegm Diseases 0.000 description 8
- 239000002994 raw material Substances 0.000 description 8
- 206010047700 Vomiting Diseases 0.000 description 7
- 230000003213 activating effect Effects 0.000 description 7
- 238000001035 drying Methods 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 239000000706 filtrate Substances 0.000 description 7
- 238000001914 filtration Methods 0.000 description 7
- 238000002156 mixing Methods 0.000 description 7
- 238000002791 soaking Methods 0.000 description 7
- 108020002663 Aldehyde Dehydrogenase Proteins 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 6
- 206010037660 Pyrexia Diseases 0.000 description 6
- 244000272264 Saussurea lappa Species 0.000 description 6
- 235000006784 Saussurea lappa Nutrition 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 230000006872 improvement Effects 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 230000035922 thirst Effects 0.000 description 6
- 206010030113 Oedema Diseases 0.000 description 5
- 208000031971 Yin Deficiency Diseases 0.000 description 5
- 239000012530 fluid Substances 0.000 description 5
- 230000006698 induction Effects 0.000 description 5
- 201000009240 nasopharyngitis Diseases 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 231100000331 toxic Toxicity 0.000 description 5
- 230000002588 toxic effect Effects 0.000 description 5
- 230000008673 vomiting Effects 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 206010068319 Oropharyngeal pain Diseases 0.000 description 4
- 240000004371 Panax ginseng Species 0.000 description 4
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 4
- 235000003140 Panax quinquefolius Nutrition 0.000 description 4
- 201000007100 Pharyngitis Diseases 0.000 description 4
- 208000003251 Pruritus Diseases 0.000 description 4
- 241001052560 Thallis Species 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 230000002075 anti-alcohol Effects 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 235000008434 ginseng Nutrition 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 210000000582 semen Anatomy 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 101150038502 ALDH2 gene Proteins 0.000 description 3
- 241000049624 Alisma plantago-aquatica subsp. orientale Species 0.000 description 3
- 244000291564 Allium cepa Species 0.000 description 3
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 3
- 241000255789 Bombyx mori Species 0.000 description 3
- 241001164374 Calyx Species 0.000 description 3
- 235000007516 Chrysanthemum Nutrition 0.000 description 3
- 244000236655 Diospyros kaki Species 0.000 description 3
- 241000628997 Flos Species 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 208000031361 Hiccup Diseases 0.000 description 3
- 201000005505 Measles Diseases 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 244000273928 Zingiber officinale Species 0.000 description 3
- 235000006886 Zingiber officinale Nutrition 0.000 description 3
- 235000013334 alcoholic beverage Nutrition 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 235000008397 ginger Nutrition 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- 206010036067 polydipsia Diseases 0.000 description 3
- 230000028527 righting reflex Effects 0.000 description 3
- 201000005404 rubella Diseases 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- 241001529821 Agastache Species 0.000 description 2
- 241001127714 Amomum Species 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 235000008597 Diospyros kaki Nutrition 0.000 description 2
- 206010016952 Food poisoning Diseases 0.000 description 2
- 208000019331 Foodborne disease Diseases 0.000 description 2
- 235000018142 Hedysarum alpinum var americanum Nutrition 0.000 description 2
- 240000006461 Hedysarum alpinum var. americanum Species 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 244000207740 Lemna minor Species 0.000 description 2
- 235000006439 Lemna minor Nutrition 0.000 description 2
- 235000006679 Mentha X verticillata Nutrition 0.000 description 2
- 235000002899 Mentha suaveolens Nutrition 0.000 description 2
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 235000001855 Portulaca oleracea Nutrition 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 240000004922 Vigna radiata Species 0.000 description 2
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 2
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 2
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 206010013990 dysuria Diseases 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 230000035987 intoxication Effects 0.000 description 2
- 231100000566 intoxication Toxicity 0.000 description 2
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 229930027917 kanamycin Natural products 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- 229960000318 kanamycin Drugs 0.000 description 2
- 229930182823 kanamycin A Natural products 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000000115 thoracic cavity Anatomy 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- NGNQZCDZXSOVQU-UHFFFAOYSA-N 8,16,18,26,34,36-hexahydroxyhentetracontane-2,6,10,14,24,28,32-heptone Chemical compound CCCCCC(O)CC(O)CC(=O)CCCC(=O)CC(O)CC(=O)CCCCCC(O)CC(O)CC(=O)CCCC(=O)CC(O)CC(=O)CCCC(C)=O NGNQZCDZXSOVQU-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000090 Abdominal rigidity Diseases 0.000 description 1
- 206010000242 Abortion threatened Diseases 0.000 description 1
- 241001633574 Adenophora stricta Species 0.000 description 1
- 241001116477 Adenophora triphylla Species 0.000 description 1
- 101000939689 Araneus ventricosus U2-aranetoxin-Av1a Proteins 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 101000633673 Buthacus arenicola Beta-insect depressant toxin BaIT2 Proteins 0.000 description 1
- 101000654318 Centruroides noxius Beta-mammal toxin Cn2 Proteins 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 101001028695 Chironex fleckeri Toxin CfTX-2 Proteins 0.000 description 1
- 240000005250 Chrysanthemum indicum Species 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 235000011511 Diospyros Nutrition 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 241001183967 Isodon Species 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 235000001188 Peltandra virginica Nutrition 0.000 description 1
- 235000011751 Pogostemon cablin Nutrition 0.000 description 1
- 240000002505 Pogostemon cablin Species 0.000 description 1
- 244000197580 Poria cocos Species 0.000 description 1
- 235000008599 Poria cocos Nutrition 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010057071 Rectal tenesmus Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241001162994 Rugosus Species 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 208000005985 Threatened Abortion Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 244000042295 Vigna mungo Species 0.000 description 1
- 235000010716 Vigna mungo Nutrition 0.000 description 1
- 235000011453 Vigna umbellata Nutrition 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 240000008866 Ziziphus nummularia Species 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 208000005298 acute pain Diseases 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 244000193174 agave Species 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 239000000924 antiasthmatic agent Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000009982 effect on human Effects 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000009465 prokaryotic expression Effects 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 238000003259 recombinant expression Methods 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 238000007921 solubility assay Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 208000012271 tenesmus Diseases 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8965—Asparagus, e.g. garden asparagus or asparagus fern
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9064—Amomum, e.g. round cardamom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0008—Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y102/00—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
- C12Y102/01—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with NAD+ or NADP+ as acceptor (1.2.1)
- C12Y102/0101—Acetaldehyde dehydrogenase (acetylating) (1.2.1.10)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y102/00—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
- C12Y102/99—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with other acceptors (1.2.99)
- C12Y102/99003—Aldehyde dehydrogenase (pyrroloquinoline-quinone) (1.2.99.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y102/00—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
- C12Y102/99—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with other acceptors (1.2.99)
- C12Y102/99007—Aldehyde dehydrogenase (FAD-independent) (1.2.99.7)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Immunology (AREA)
Abstract
The invention provides a production method, a composition and a preparation of acetaldehyde dehydrogenase for alleviating hangover and protecting liver. A production method of acetaldehyde dehydrogenase for alleviating hangover and protecting liver comprises the following steps: inoculating the engineering bacteria of Escherichia coli into a fermentation culture medium, and performing fermentation culture at 25-37 deg.C for 6-8 h; collecting the thallus, carrying out ultrasonication, and separating and purifying ALDH2 protein. The invention can not only quickly relieve discomfort after drinking, but also effectively protect and nourish intestines, stomach and liver, and has good development potential.
Description
Technical Field
The invention relates to the technical field of biology, and in particular relates to a production method, a composition and a preparation of acetaldehyde dehydrogenase.
Background
At present, the antialcoholic products on the market are mainly chemical drugs. Most of the chemicals are components such as stimulants, vitamins and amino acids, and can quickly achieve the effects of dispelling the effects of alcohol and sobering up, but most of the chemical anti-alcohol mechanisms are only capable of promoting alcohol decomposition to achieve a temporary relieving effect, the liver protection effect is difficult to achieve, and the toxic and side effects are large.
Disclosure of Invention
The present invention overcomes at least one of the deficiencies of the prior art described above,
an object of the present invention is to provide a method for producing acetaldehyde dehydrogenase, comprising the steps of:
s1, inoculating an escherichia coli engineering bacterium expressing an acetaldehyde dehydrogenase gene into a fermentation culture medium for culture;
s2, collecting thalli, and separating and purifying after carrying out ultrasonic crushing.
Further, fermenting and culturing for 6-8h at 25-37 ℃.
Further, fermenting and culturing for 6-8h at 25 ℃.
The invention also aims to provide an acetaldehyde dehydrogenase composition for relieving alcoholism, which comprises the following components in parts by weight: 1-10 parts of acetaldehyde dehydrogenase obtained by the production method of the acetaldehyde dehydrogenase, 40-80 parts of kudzu root extract, 10-50 parts of dried orange peel extract, 10-50 parts of fructus amomi extract, 20-40 parts of flos puerariae extract, 15-30 parts of chinaroot greenbrier rhizome extract, 10-30 parts of small bean flower extract, 10-30 parts of elecampane extract, 10-30 parts of radix asparagi extract, 10-30 parts of moutan bark extract, 10-30 parts of rhizoma alismatis extract and 10-30 parts of liquorice extract.
Further, the composition comprises the following components in parts by weight: 5 parts of acetaldehyde dehydrogenase obtained by the production method of the acetaldehyde dehydrogenase, 60 parts of kudzu root extract, 30 parts of dried orange peel extract, 30 parts of fructus amomi extract, 40 parts of pueraria flower extract, 20 parts of chinaroot greenbrier rhizome extract, 20 parts of small bean flower extract, 15 parts of elecampane extract, 15 parts of radix asparagi extract, 10 parts of moutan bark extract, 10 parts of rhizoma alismatis extract and 10 parts of liquorice extract.
The invention also aims to provide an anti-alcohol liver-protecting acetaldehyde dehydrogenase composition preparation, which comprises the anti-alcohol liver-protecting acetaldehyde dehydrogenase composition.
Furthermore, the composition also comprises pharmaceutically acceptable auxiliary materials.
Further, the coating also comprises at least one of excipient, binder, bulking agent, lubricant, antioxidant, preservative or thickening agent.
Further, the preparation is an oral preparation.
Furthermore, the preparation can be prepared into tablets, powder, pills, capsules, granules or oral liquid.
Compared with the prior art, the technical scheme of the invention has the beneficial effects that:
the invention provides an acetaldehyde dehydrogenase composition with anti-intoxication and anti-alcoholism effects and a preparation method thereof, wherein the acetaldehyde dehydrogenase composition comprises the following components: acetaldehyde dehydrogenase, a kudzu root extract, a dried orange peel extract, a fructus amomi extract, a pueraria flower extract, a white poria extract, a small bean flower extract, a costus root extract, an asparagus root extract, a tree peony bark extract, an alisma orientale extract and a liquorice root extract are combined according to different proportions to fully play the synergistic effect. Animal experiments show that the composition prepared by the invention has obvious anti-intoxication and anti-alcoholism effects, can fundamentally remove acetaldehyde, has the functions of harmonizing the stomach and protecting the liver, and achieves the purposes of anti-alcoholism and protecting the liver. The composition has simple preparation process, can be subjected to large-scale industrial production, and has wide application prospect in preparation of health care products or foods with the effects of resisting and neutralizing the effect of alcoholic drinks.
The acetaldehyde dehydrogenase composition for resisting and neutralizing the effect of alcoholic drinks can fundamentally remove acetaldehyde, has the effects of harmonizing the stomach and protecting the liver, and achieves the purposes of neutralizing the effect of alcoholic drinks and protecting the liver. No chemical reagent and toxic substance are used in the extraction and preparation processes, so that the preparation is safe and effective, has definite treatment purpose and good development potential.
Drawings
FIG. 1 is an electrophoretogram of PCR products of ALDH2 of the present invention.
FIG. 2 shows the induction of expression of ALDH2 in the present invention.
FIG. 3 shows the induction of ALDH2 expression at different temperatures in the present invention.
FIG. 4 shows the solubility analysis and identification of ALDH2 protein in the present invention.
FIG. 5 shows the differentiation and purification of ALDH2 protein in the present invention.
FIG. 6 is a standard curve of the activity of the enzyme of the present invention.
FIG. 7 shows the effect of acetaldehyde dehydrogenase (ALDH2) composition of the present invention on the intoxication and sobering of mice.
Detailed Description
The drawings are for illustrative purposes only and are not to be construed as limiting the patent; instruments and medicines used in the application are all commercially available if not specifically stated; it will be understood by those skilled in the art that certain well-known structures and descriptions thereof may be omitted.
The invention provides a production method of acetaldehyde dehydrogenase, which comprises the following steps:
s1, inoculating an escherichia coli engineering bacterium expressing an acetaldehyde dehydrogenase gene into a fermentation culture medium for culture;
s2, collecting thalli, and separating and purifying after carrying out ultrasonic crushing.
As an improvement of the specific embodiment, the fermentation culture is carried out for 6-8h at 25-37 ℃.
As an improvement of the specific embodiment, the fermentation culture is carried out for 6-8h at 25 ℃.
The invention also provides an acetaldehyde dehydrogenase composition for relieving alcoholism, which comprises the following components in parts by weight: 1-10 parts of acetaldehyde dehydrogenase obtained by the production method of the acetaldehyde dehydrogenase, 40-80 parts of kudzu root extract, 10-50 parts of dried orange peel extract, 10-50 parts of fructus amomi extract, 20-40 parts of flos puerariae extract, 15-30 parts of chinaroot greenbrier rhizome extract, 10-30 parts of small bean flower extract, 10-30 parts of elecampane extract, 10-30 parts of radix asparagi extract, 10-30 parts of moutan bark extract, 10-30 parts of rhizoma alismatis extract and 10-30 parts of liquorice extract.
As an improvement of the specific embodiment, the composition comprises the following components in parts by weight: 5 parts of acetaldehyde dehydrogenase obtained by the production method of the acetaldehyde dehydrogenase, 60 parts of kudzu root extract, 30 parts of dried orange peel extract, 30 parts of fructus amomi extract, 40 parts of pueraria flower extract, 20 parts of chinaroot greenbrier rhizome extract, 20 parts of small bean flower extract, 15 parts of elecampane extract, 15 parts of radix asparagi extract, 10 parts of moutan bark extract, 10 parts of rhizoma alismatis extract and 10 parts of liquorice extract.
The invention also provides an alcohol-relieving liver-protecting acetaldehyde dehydrogenase composition preparation, which comprises the alcohol-relieving liver-protecting acetaldehyde dehydrogenase composition.
As an improvement of the specific embodiment, the composition also comprises pharmaceutically acceptable auxiliary materials.
As a refinement of a particular embodiment, at least one of an excipient, a binder, a filler, a lubricant, an antioxidant, a preservative, or a thickener is further included.
As a modification of the specific embodiment, the formulation is an oral formulation.
As an improvement of the specific embodiment, the preparation is in the form of tablets, powder, pills, capsules, granules or oral liquid.
DETAILED DESCRIPTION OF EMBODIMENT (S) OF INVENTION
Preparing acetaldehyde dehydrogenase materials:
1. preparation of ALDH2 Gene
The ALDH2 gene fragment which is optimized and stored before the laboratory is used as a template, NcoI enzyme cutting sites and Xho I enzyme cutting sites are respectively introduced into the upstream and the downstream, and the ALDH2 gene fragment is amplified (figure 1). The reaction products were identified by electrophoresis on a 1% agarose gel. The PCR product ALDH2 was recovered and purified by gel. Plasmid extraction and gel recovery steps were performed according to the instructions of the OMEGA gel recovery kit.
FIG. 1 is an electrophoretogram of the PCR product of ALDH 2. The results showed a product length of 1500 bp, consistent with the expected results.
1.2, constructing pet-28a-aldh2 recombinant expression plasmid:
2. induced expression and purification of acetaldehyde dehydrogenase protein
2.1, transformation of the recombinant plasmid pET-28a-aldh 2:
the correctly identified recombinant plasmid pET-28a-aldh2 was transformed into competent cells of E.coli BL21(DE 3). Positive monoclonal strains were screened on resistant (kanamycin at 100. mu.g/ml) plates.
2.2 screening of ALDH2 expression bacteria and optimization of optimal expression conditions
A plurality of randomly selected monoclonal colonies were inoculated into 5ml of LB medium (LB medium formulation: tryptone: 10g/L, yeast extract: 5g/L, sodium chloride: 10g/L, NaOH-adjusted medium pH at 7.4, containing 100. mu.g/ml kanamycin) and cultured at 37 ℃ and 180 rpm until OD600 = 0.6-0.8. Taking 1ml as an uninduced control, adding IPTG (isopropyl-beta-D-thiogalactoside) to a final concentration of 1mmol/L, inducing at 37 ℃ for 6h, centrifuging to collect thalli, and performing 10% SDS-PAGE analysis after thalli precipitation treatment. The results show that the selected 4 single clones can express the target protein (figure 2), and the protein expression has no obvious difference at different temperatures (figure 3), so that the protein expression is carried out under the condition that the protein expression is favorable for soluble protein expression at 25 ℃, and the protein is mainly expressed in a soluble mode after the identification of solubility analysis (figure 4). Therefore, the supernatant after ultrasonication is subjected to protein separation and purification by using a nickel column protein purification system, and finally the desired target protein is obtained in 300mM imidazole eluent (figure 5), and the enzyme activity per unit volume is 1886.9U/L after enzyme activity detection (Table 1).
FIG. 2 shows the induction of expression of ALDH 2. 1: an untransformed control; 2.3, 4, 5: 4 single clones were picked and induced to express. The results show that the protein expression is obvious at about 55 kd.
2.3 determination of Induction temperature
FIG. 3 shows the induction of ALDH2 expression at different temperatures. 1. Untransformed control 2, 25 ℃ induced expression; 3. inducing expression at 30 ℃; 4. expression was induced at 37 ℃. The result shows that the protein can generate higher target protein amount at 25-37 ℃, and the low temperature is favorable for a prokaryotic expression system to induce and generate soluble protein, so that the subsequent experiment is carried out at 25 ℃.
2.4 solubility analysis and identification
FIG. 4 shows the ALDH2 protein solubility assay. 1. Untransformed control 2, supernatant after induced expression ultrasonication; 3. inducing expression, ultrasonic breaking and depositing. The results showed that a portion of the ALDH2 protein was expressed in soluble form (a distinct protein band at 55kd in the supernatant after ultrasonication).
2.5 purification of ALDH2 protein
FIG. 5 shows the ALDH2 protein differentiation purification. 1. Identifying supernatant after induced expression and ultrasonic disruption; 2. elution with 50mM imidazole; 3. 75mM imidazole; 4. 300mM imidazole. The results showed a clear band of interest in the 300mM eluate, which was assayed at a protein concentration of 183 mg/L.
2.6 detection of ALDH2 Activity
The activity detection is carried out by using Nanjing-derived ALDH2 enzyme activity detection kit, and a standard curve (U/200 ul) is established by using Shanghai-derived leaf ALDH2 enzyme activity standard substance as shown in figure 6. The activity of the extracted ALDH2 protease is shown in Table 1, and the unit volume activity of the protease is 1886.9U/L.
TABLE 1 ALDH2 enzyme activity assay
Absorbance Change Δ A (340 nm) | Unit volume enzyme activity (U/L) |
0.0392 | 1886.9 |
Example 1
An acetaldehyde dehydrogenase composition for resisting and neutralizing the effect of alcohol, which is prepared from the following raw materials in parts by weight: 10 parts of acetaldehyde dehydrogenase, 80 parts of kudzu root extract, 50 parts of dried orange peel extract, 50 parts of fructus amomi extract, 40 parts of pueraria flower extract, 30 parts of chinaroot greenbrier rhizome extract, 30 parts of small bean flower extract, 30 parts of costustoot extract, 30 parts of radix asparagi extract, 30 parts of moutan bark extract, 30 parts of rhizoma alismatis extract and 30 parts of liquorice extract. The preparation method of the extracts of the components comprises the following steps: soaking the medicinal materials in water for 1-2 hr, and decocting with water twice, wherein the amount of water added is 3-5 times of the weight of the medicinal materials each time; during decoction, the mixture is boiled by strong fire and then decocted by slow fire until the ratio of liquid to dregs in the medicament is 0.5-1: 1; filtering the obtained medicinal liquid with gauze, mixing filtrates, concentrating, and drying to obtain extract.
Example 2
An acetaldehyde dehydrogenase composition for resisting and neutralizing the effect of alcohol, which is prepared from the following raw materials in parts by weight: 5 parts of acetaldehyde dehydrogenase, 50 parts of kudzu root extract, 30 parts of dried orange peel extract, 20 parts of fructus amomi extract, 20 parts of pueraria flower extract, 20 parts of chinaroot greenbrier rhizome extract, 15 parts of small bean flower extract, 20 parts of costus root extract, 15 parts of cochinchnese asparagus root extract, 15 parts of tree peony bark extract, 20 parts of rhizoma alismatis extract and 10 parts of liquorice extract. The preparation method of the extracts of the components comprises the following steps: soaking the medicinal materials in water for 1-2 hr, and decocting with water twice, wherein the amount of water added is 3-5 times of the weight of the medicinal materials each time; during decoction, the mixture is boiled by strong fire and then decocted by slow fire until the ratio of liquid to dregs in the medicament is 0.5-1: 1; filtering the obtained medicinal liquid with gauze, mixing filtrates, concentrating, and drying to obtain extract.
Example 3
An acetaldehyde dehydrogenase composition for resisting and neutralizing the effect of alcohol, which is prepared from the following raw materials in parts by weight: 3 parts of acetaldehyde dehydrogenase, 40 parts of kudzu root extract, 20 parts of dried orange peel extract, 30 parts of fructus amomi extract, 20 parts of pueraria flower extract, 15 parts of chinaroot greenbrier rhizome extract, 10 parts of small bean flower extract, 10 parts of costus root extract, 10 parts of cochinchnese asparagus root extract, 10 parts of tree peony bark extract, 10 parts of rhizoma alismatis extract and 10 parts of liquorice extract. The preparation method of the extracts of the components comprises the following steps: soaking the medicinal materials in water for 1-2 hr, and decocting with water twice, wherein the amount of water added is 3-5 times of the weight of the medicinal materials each time; during decoction, the mixture is boiled by strong fire and then decocted by slow fire until the ratio of liquid to dregs in the medicament is 0.5-1: 1; filtering the obtained medicinal liquid with gauze, mixing filtrates, concentrating, and drying to obtain extract.
Example 4
An acetaldehyde dehydrogenase composition for resisting and neutralizing the effect of alcohol, which is prepared from the following raw materials in parts by weight: 6 parts of acetaldehyde dehydrogenase, 60 parts of kudzu root extract, 20 parts of dried orange peel extract, 30 parts of fructus amomi extract, 35 parts of pueraria flower extract, 25 parts of chinaroot greenbrier rhizome extract, 25 parts of small bean flower extract, 20 parts of costus root extract, 20 parts of cochinchnese asparagus root extract, 15 parts of tree peony bark extract, 10 parts of rhizoma alismatis extract and 15 parts of liquorice extract. The preparation method of the extracts of the components comprises the following steps: soaking the medicinal materials in water for 1-2 hr, and decocting with water twice, wherein the amount of water added is 3-5 times of the weight of the medicinal materials each time; during decoction, the mixture is boiled by strong fire and then decocted by slow fire until the ratio of liquid to dregs in the medicament is 0.5-1: 1; filtering the obtained medicinal liquid with gauze, mixing filtrates, concentrating, and drying to obtain extract.
Example 5
An acetaldehyde dehydrogenase composition for resisting and neutralizing the effect of alcohol, which is prepared from the following raw materials in parts by weight: 4 parts of acetaldehyde dehydrogenase, 50 parts of kudzu root extract, 20 parts of dried orange peel extract, 20 parts of fructus amomi extract, 30 parts of pueraria flower extract, 20 parts of chinaroot greenbrier rhizome extract, 25 parts of small bean flower extract, 15 parts of costustoot extract, 15 parts of radix asparagi extract, 10 parts of moutan bark extract, 10 parts of rhizoma alismatis extract and 15 parts of liquorice extract. The preparation method of the extracts of the components comprises the following steps: soaking the medicinal materials in water for 1-2 hr, and decocting with water twice, wherein the amount of water added is 3-5 times of the weight of the medicinal materials each time; during decoction, the mixture is boiled by strong fire and then decocted by slow fire until the ratio of liquid to dregs in the medicament is 0.5-1: 1; filtering the obtained medicinal liquid with gauze, mixing filtrates, concentrating, and drying to obtain extract.
Example 6
An acetaldehyde dehydrogenase composition for resisting and neutralizing the effect of alcohol, which is prepared from the following raw materials in parts by weight: 4 parts of acetaldehyde dehydrogenase, 45 parts of kudzu root extract, 10 parts of dried orange peel extract, 15 parts of fructus amomi extract, 30 parts of pueraria flower extract, 15 parts of chinaroot greenbrier rhizome extract, 15 parts of small bean flower extract, 10 parts of costus root extract, 10 parts of cochinchnese asparagus root extract, 15 parts of tree peony bark extract, 10 parts of rhizoma alismatis extract and 15 parts of liquorice extract. The preparation method of the extracts of the components comprises the following steps: soaking the medicinal materials in water for 1-2 hr, and decocting with water twice, wherein the amount of water added is 3-5 times of the weight of the medicinal materials each time; during decoction, the mixture is boiled by strong fire and then decocted by slow fire until the ratio of liquid to dregs in the medicament is 0.5-1: 1; filtering the obtained medicinal liquid with gauze, mixing filtrates, concentrating, and drying to obtain extract.
Example 7
An acetaldehyde dehydrogenase composition for resisting and neutralizing the effect of alcohol, which is prepared from the following raw materials in parts by weight: 5 parts of acetaldehyde dehydrogenase, 50 parts of kudzu root extract, 30 parts of dried orange peel extract, 20 parts of fructus amomi extract, 20 parts of pueraria flower extract, 20 parts of chinaroot greenbrier rhizome extract, 15 parts of small bean flower extract, 20 parts of costus root extract, 15 parts of cochinchnese asparagus root extract, 20 parts of oriental waterplantain rhizome extract and 10 parts of liquorice root extract. The preparation method of the extracts of the components comprises the following steps: soaking the medicinal materials in water for 1-2 hr, and decocting with water twice, wherein the amount of water added is 3-5 times of the weight of the medicinal materials each time; during decoction, the mixture is boiled by strong fire and then decocted by slow fire until the ratio of liquid to dregs in the medicament is 0.5-1: 1; filtering the obtained medicinal liquid with gauze, mixing filtrates, concentrating, and drying to obtain extract. During the second decoction, the following raw materials in parts by weight can be added: 10 parts of wild jujube, 5 parts of ginseng, 10 parts of mung bean, 10 parts of adenophora stricta, 10 parts of persimmon calyx, 10 parts of asparagus, 10 parts of duckweed, 10 parts of silkworm excrement, 10 parts of pogostemon cablin, 10 parts of semen hominis, 10 parts of ginger, 10 parts of linearstripe rabdosia herb, 10 parts of fistular onion stalk and 10 parts of chrysanthemum.
According to the traditional Chinese medicine, the treatment is based on the basic principle of relieving alcoholism, clearing heat and eliminating dampness, wherein the alcoholism is eliminated throughout the treatment, and methods such as reducing phlegm and eliminating dampness, promoting the circulation of qi and removing stagnancy, tonifying qi and strengthening spleen, warming middle-jiao and activating blood, lowering adverse qi and harmonizing stomach are mostly adopted. The traditional Chinese medicine composition takes the kudzuvine root, the kudzuvine flower and the rice bean flower as monarch drugs and is good at relieving alcoholism and activating the spleen, the kudzuvine flower and the kudzuvine root are traditional alcoholism relieving drugs, and the kudzuvine flower has the most prominent effect of relieving alcoholism and activating the spleen. Pueraria root, radix Puerariae has the action of expelling pathogenic factors from the muscles and skin and relieving damp-heat from the exterior. The ministerial drugs use the amomum fruit to eliminate dampness and promote qi circulation, warm the middle-jiao to stop diarrhea, the ginger helps to invigorate spleen qi, and eliminate dampness and activate the middle-jiao to invigorate the spleen; poria, Alismatis rhizoma, herba Spirodelae, herba Agastaches, herba Rabdosiae Lophanthoidis, and semen Phaseoli Radiati are used for promoting diuresis and eliminating dampness, and guiding wine dampness to relieve constipation; radix aucklandiae, pericarpium Citri Reticulatae, calyx kaki and semen Hoveniae are used to regulate qi, relieve stagnation, regulate middle energizer, eliminate dampness and phlegm, and promote the dispelling of alcohol and qi in the body; silkworm excrement and ginseng are used for tonifying middle-jiao, strengthening spleen, replenishing primordial qi, tonifying qi, strengthening body resistance and nourishing stomach, and radix adenophorae and radix asparagi are used for replenishing yin liquid; the spina date seed is used for nourishing the heart and soothing the nerves, the fistular onion stalk is used for activating yang and refreshing the mind, and the mint and the chrysanthemum enter the liver channel to clear away the heat and improve the eyesight; the liquorice is used for harmonizing the medicines and has the effects of detoxifying and promoting diuresis, soothing liver and purging heat, dispelling alcohol dampness and removing stagnation by combining the medicines; the health-care tea has the effects of reducing blood pressure, blood fat and blood sugar, resisting aging and fatigue, relaxing bowel, protecting liver, nourishing stomach, beautifying and moistening skin, improving human immunity, protecting liver, harmonizing stomach, promoting urination, clearing heat, detoxifying, relieving summer heat, relieving restlessness, beautifying and moistening skin, clearing lung, relieving cough, dispelling alcohol effect, dispelling wind, cooling blood, quickly and safely dispelling alcohol effect, has no toxic or side effect on human bodies, and has obvious effect.
Reference of drug efficacy:
kudzu root, wind-heat-dispersing medicine: relieving muscles and fever, promoting eruption, promoting fluid production to quench thirst, invigorating yang and relieving diarrhea (1. fever exterior syndrome, strong pain on neck and back 2. measles without adequate eruption 3. fever thirst, yin deficiency and thirst 4. fever diarrhea, spleen deficiency and diarrhea)
Dried orange peel, qi-regulating herbs: regulate qi to invigorate spleen, dry dampness and resolve phlegm. (1, syndrome of qi stagnation in spleen and stomach 2. emesis, hiccup 3. phlegm-dampness, cold-phlegm cough 4. thoracic obstruction)
Amomum fruit, dampness-resolving herbs: resolve dampness, promote qi circulation, warm middle energizer to arrest diarrhea, prevent abortion. (1. syndrome of dampness obstruction in middle energizer and qi stagnation in spleen and stomach 2. vomiting and diarrhea due to deficiency-cold in spleen and stomach 3. aversion to pregnancy due to qi stagnation and threatened abortion)
Pueraria flower, wind-heat-dispersing medicine: relieving alcoholism, activating spleen and regulating stomach. Can be used for treating excessive drinking, headache, dizziness, polydipsia, emesis, and chest and diaphragm fullness
Tuckahoe, diuretic detumescence drugs: induce diuresis and drain dampness, invigorate spleen and calm heart. (1. edema 2. phlegm and fluid 3. spleen deficiency diarrhea 4. palpitation insomnia)
Alisma orientale, diuresis-inducing and edema-alleviating herbs: induce diuresis to drain dampness and purge heat. (1. edema, dysuria, diarrhea 2. stranguria, spermatorrhea)
Aucklandia root, qi-regulating herbs: promoting qi circulation, relieving pain, invigorating spleen, and promoting digestion. (1. spleen and stomach qi stagnation syndrome 2. diarrhea and dysentery with tenesmus 3. abdominal pain and hypochondriac pain, jaundice, hernia pain 4. thoracic obstruction)
Chizuki bean flower has the effects of clearing heat, quenching thirst, sobering up and detoxifying. (malaria, dysentery, diabetes, headache due to injury or drinking, haemorrhoids and fistula, erysipelas, furuncle)
Licorice, a qi-tonifying drug: invigorating spleen and replenishing qi, eliminating phlegm and relieving cough, relieving spasm and pain, clearing away heat and toxic materials, and harmonizing the recipe. (1. heart-qi deficiency, intermittent pulse, palpitation, 2. spleen-qi deficiency syndrome, 3. cough and asthma, 4. epigastric and abdominal spasm, acute pain, 5. toxic heat, sore and abscess, sore throat, medicine and food poisoning, 6. harmonize medicine property)
Spina date seed, heart-nourishing and nerve-soothing medicine: nourishing heart, benefiting liver, tranquilizing, arresting sweating, and promoting fluid production. (1. palpitation insomnia 2. spontaneous perspiration, night sweat)
Mung bean, heat-clearing and toxicity-removing herbs: clearing away heat and toxic material, relieving summer-heat, and inducing diuresis (1. carbuncle, swelling, sore, toxin 2. summer-heat polydipsia 3. medicine and food poisoning 4. edema, dysuria)
Bitter apricot seeds, antitussive and antiasthmatic herbs: relieving cough and asthma, loosening bowel to relieve constipation (1. cough and asthma 2. constipation due to intestinal dryness)
Adenophora tetraphylla, yin-tonifying herbs: nourishing yin to clear away the lung-heat, benefiting the stomach and promoting the production of body fluid, invigorating qi and resolving phlegm (1. lung yin deficiency syndrome 2. stomach yin deficiency syndrome)
Calyx kaki, qi-regulating herbs: directing qi downward to stop hiccup (hiccup)
Asparagus, yin-tonifying herbs: to nourish yin, moisten dryness, clear lung and promote fluid production. (1. Lung yin deficiency syndrome 2. Kidney yin deficiency syndrome 3. fever impairment of body fluids caused by inappetence, thirst and constipation due to intestinal dryness)
Duckweed, wind-heat-dispersing drug: inducing sweat to relieve exterior syndrome, promoting eruption, relieving itching, inducing diuresis, and relieving swelling (1. wind-heat type common cold 2. measles without adequate eruption 3. rubella pruritus 4. edema oliguria)
Silkworm excrement, wind-cold-dampness-dispelling medicine: dispelling wind-damp, harmonizing stomach and resolving dampness (1. rheumatism 2. vomiting and diarrhea and spasm 3. rubella, eczema)
Agastache rugosus, dampness-resolving herbs: resolving dampness, arresting vomiting, relieving summer-heat (1. damp obstruction of middle energizer 2. vomiting 3. summer-heat dampness or early stage of damp-warm disease)
The ginseng, semen homalomenae, invigorates the stomach; promoting the secretion of saliva; sobering up; and (5) detoxifying. Mainly treats inappetence; thirst due to febrile disease; drunkenness; swollen and sore throat; sores and itching due to wind-toxin.
Ginseng, qi tonics: invigorating primordial qi, invigorating spleen, benefiting lung, promoting fluid production, tranquilizing mind, and improving intelligence (1. primordial qi deficiency syndrome 2. lung spleen heart kidney qi deficiency syndrome 3. fever with qi deficiency and body fluid consumption
Ginger, wind-cold-dispersing herbs: relieving exterior syndrome, dispelling cold, warming middle energizer, relieving vomiting, warming lung, and relieving cough (1. wind-cold type common cold 2. spleen and stomach cold syndrome 3. cough due to lung cold)
Herba Rabdosiae Lophanthoidis (herba Gei Repentis), herba Rabdosiae Lophanthoidis has effects of clearing heat, promoting diuresis, eliminating jaundice, eliminating dampness, cooling blood and removing blood stasis
Fistular onion stalk, wind-cold-dispersing medicine: inducing sweat to relieve exterior syndrome, dispelling cold and activating yang (1. wind-cold type common cold 2. exuberance of yin and yang)
Chrysanthemum, wind-heat-dispersing herbs: dispelling wind-heat, suppressing liver-yang, clearing liver-heat, improving eyesight, clearing heat and detoxicating (1. wind-heat type common cold, warm disease onset 2. liver-yang vertigo, liver-wind excess syndrome 3. conjunctival congestion and coma 4. sore and carbuncle pyogenic infections)
Mint, wind-heat-dispersing medicine: dispelling wind-heat, clearing head and eyes, relieving sore throat, promoting eruption, dispersing stagnated liver qi, and activating qi-flowing (1. wind-heat type common cold, warm disease onset 2. wind-heat type headache, conjunctival congestion with lacrimation, sore throat 3. measles without adequate eruption, rubella pruritus 4. stagnation of liver-qi, chest distress and hypochondriac pain)
Animal test conditions were as follows:
1. experimental Material
ALDH2 composition (ALDH 2+ Chinese traditional medicine): kudzu root, dried orange peel, fructus amomi, flos puerariae lobatae, white poria, small bean flower, costustoot, radix asparagi, moutan bark, rhizoma alismatis, liquorice and the like are purchased from Dashenlin pharmacy, extracts are prepared according to the original formula proportion, and are uniformly mixed with acetaldehyde dehydrogenase (ALDH2) for later use. According to the conversion method of the drug for animal pharmacology experiments and the conventional dosage of adults, the drug administration dosage is designed according to the crude drug of 10 g/kg of mouse body weight in the experiments. The drug concentration was adjusted with distilled water in an administration volume of 0.1mL (drug solution)/10 g (mouse body weight) before the experiment.
The animal experiments were as follows:
60 SPF-level Kunming mice with the weight of 18-22g are taken and provided by the experimental animal center of Guangdong province. After 1 week of adaptive feeding, mice were randomly divided into 6 groups (blank control group, model group, ALDH2 single-dose group, ALDH2 multiple-dose group, ALDH2 composition (ALDH 2+ chinese medicine) single-dose group, ALDH2 composition (ALDH 2+ chinese medicine) multiple-dose group), 10 mice per group. Mice were fasted without water deprivation for 12 h prior to treatment. The experimental group mice were gavaged with 56% vol niu bangshan Erguotou at 15 ml/kg body weight, and then administered with the following drugs: the test results sequentially comprise a model group, an ALDH2 single-dose group, an ALDH2 multi-dose group, an ALDH2 single-dose group and an ALDH2 multi-dose group.
Two modes of administration were used in the experiment. The first administration mode is three times of administration before, during and after drinking wine, 100ul of aqueous extract each time; wherein the administration time before drinking is recorded as-30 min, the administration time in drinking is recorded as 0min, and the administration time after drinking is recorded as 30 min. The second way is to administer the drug just once before the wine. The behavioral indexes of each group are measured at 30min after drinking, the observation lasts for 4h, the activity of each group of mice is observed, and the number of drunk mice, the number of dead mice, the drinking time, the disappearance time of righting reflex and the recovery time of righting reflex are recorded. The drunk time is the righting reflex recovery time-righting reflex disappearance time;
as can be seen from table 2 and fig. 7, 10 mice in the model group were all drunk, the drunk rate was 100%, and only 2 mice were sobered within 4 hours, and the sobered rate was 20%. The alcoholism rate of the ALDH2 multi-dose group is only 40%, and the alcoholism mice are fully sobered within 4h, and the sobering rate is 100%. The alcoholism rate of the ALDH2 single-dose group is 100%, and the alcoholism rate of the drunk mice is 50% within 4 h. The alcoholism rate of the ALDH2 composition multi-dose group is 40%, and the alcoholism rate within 4h is 100% which is the same as that of the ALDH2 multi-dose group, but compared with the ALDH2 multi-dose group, the alcoholism time of the alcoholism mice in the ALDH2 composition multi-dose group is obviously reduced to 87.75 +/-8.77 min. In addition, the single-dose group of the ALDH2 composition showed a 30% increase in the anti-hangover rate compared to the single-dose group of ALDH 2. The drunk time is also obviously reduced from 210.38 +/-26.69 min to 114.625 +/-36.15 min. The ALDH2 composition can obviously reduce the drunk time of drunk mice and accelerate sobering up.
TABLE 2 Effect of acetaldehyde dehydrogenase (ALDH2) composition on intoxication status and time in mice
Group of | Quantity (only) | Drunk number (only) | Drunkenness rate | Death number (only) | Sobering-up quantity of drunk mouse | Percentage of sobering up | Drunk time (min) of drunk mouse |
Blank group | 10 | 0 | 0 | 0 | - | - | - |
Model set | 10 | 10 | 100% | 0 | 2 | 20% | 236.50±7.01 |
ALDH2 multi-dose group | 10 | 4 | 40% | 0 | 4 | 100% | 137.25±27.11** |
ALDH2 single administration group | 10 | 10 | 100 % | 0 | 5 | 50% | 210.38±26.69 |
Multiple administration of ALDH2 compositionMedicine group | 10 | 4 | 40% | 0 | 4 | 100% | 87.75±8.77*** |
ALDH2 composition single administration group | 10 | 10 | 100% | 0 | 8 | 80% | 114.625±36.15* |
It should be understood that the above-described embodiments of the present invention are merely examples for clearly illustrating the present invention, and are not intended to limit the embodiments of the present invention. Other variations and modifications will be apparent to persons skilled in the art in light of the above description. And are neither required nor exhaustive of all embodiments. Any modification, equivalent replacement, and improvement made within the spirit and principle of the present invention should be included in the protection scope of the claims of the present invention.
Claims (7)
1. An acetaldehyde dehydrogenase composition for relieving alcoholism, which is characterized by comprising the following components in parts by weight: 1-10 parts of acetaldehyde dehydrogenase, 40-80 parts of kudzu root extract, 10-50 parts of dried orange peel extract, 10-50 parts of fructus amomi extract, 20-40 parts of pueraria flower extract, 15-30 parts of white poria extract, 10-30 parts of small bean flower extract, 10-30 parts of elecampane extract, 10-30 parts of radix asparagi extract, 10-30 parts of moutan bark extract, 10-30 parts of rhizoma alismatis extract and 10-30 parts of liquorice extract.
2. The acetaldehyde dehydrogenase composition for alleviating hangover according to claim 1, wherein the composition comprises, in parts by weight: 5 parts of acetaldehyde dehydrogenase, 60 parts of kudzu root extract, 30 parts of dried orange peel extract, 30 parts of fructus amomi extract, 40 parts of pueraria flower extract, 20 parts of chinaroot greenbrier rhizome extract, 20 parts of small bean flower extract, 15 parts of costustoot extract, 15 parts of cochinchnese asparagus root extract, 10 parts of tree peony bark extract, 10 parts of rhizoma alismatis extract and 10 parts of liquorice extract.
3. An anti-hangover and hepatoprotective acetaldehyde dehydrogenase composition preparation, comprising the anti-hangover and hepatoprotective acetaldehyde dehydrogenase composition according to any one of claims 1 to 2.
4. The composition preparation for alleviating hangover and protecting liver acetaldehyde dehydrogenase as claimed in claim 3, further comprising pharmaceutically acceptable excipients.
5. The composition preparation of claim 3, further comprising at least one of an excipient, a binder, a filler, a lubricant, an antioxidant, a preservative or a thickener.
6. The preparation of the composition for relieving alcoholism and protecting liver acetaldehyde dehydrogenase of claim 3, wherein the preparation is an oral preparation.
7. The composition preparation for relieving alcoholism and protecting liver acetaldehyde dehydrogenase as claimed in claim 3, wherein the dosage form of the preparation is tablet, powder, pill, capsule, granule or oral liquid.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010925634.3A CN111808877A (en) | 2020-09-07 | 2020-09-07 | Production method, composition and preparation of acetaldehyde dehydrogenase |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010925634.3A CN111808877A (en) | 2020-09-07 | 2020-09-07 | Production method, composition and preparation of acetaldehyde dehydrogenase |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111808877A true CN111808877A (en) | 2020-10-23 |
Family
ID=72860025
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010925634.3A Pending CN111808877A (en) | 2020-09-07 | 2020-09-07 | Production method, composition and preparation of acetaldehyde dehydrogenase |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111808877A (en) |
Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102178937A (en) * | 2011-04-27 | 2011-09-14 | 珠海市御品堂生物科技有限公司 | Pharmaceutical composition for protecting liver and benefiting spleen and preparation method thereof |
CN103143003A (en) * | 2013-03-22 | 2013-06-12 | 武汉工程大学 | Healthcare product for relieving hangover and protecting liver |
CN108103081A (en) * | 2018-02-13 | 2018-06-01 | 淄博职业学院 | A kind of acetaldehyde dehydrogenase and its application in terms of alcohol-neutralize healthy product |
CN109329941A (en) * | 2018-12-19 | 2019-02-15 | 九仙尊霍山石斛股份有限公司 | A kind of Dendrobidium huoshanness relieves the effect of alcohol particle and preparation method thereof |
WO2019140479A1 (en) * | 2018-01-19 | 2019-07-25 | Clever Health Pty Ltd | Compositions and methods for the prophylaxis or treatment of a condition associated with alcohol consumption |
CN110101849A (en) * | 2019-04-12 | 2019-08-09 | 暨南大学 | A kind of composition and the preparation method and application thereof of enzymatic antialcoholism action |
CN110123952A (en) * | 2018-02-08 | 2019-08-16 | 深圳波顿香料有限公司 | A kind of anti-alcoholism liver protecting compound preparation and its application |
CN110269166A (en) * | 2019-07-04 | 2019-09-24 | 北京九前健康科技有限公司 | A kind of preparation method of relieving alcoholism and protecting liver composition and drink and drink |
WO2019209123A1 (en) * | 2018-04-27 | 2019-10-31 | Remedius Biotech Limited | Diagnosis, risk reduction and treatment of conditions associated with elevated aldehyde levels |
CN110432418A (en) * | 2018-05-05 | 2019-11-12 | 陈泂杉 | A kind of production method of liver-protecting and alcoholism-relieving drink |
CN110734890A (en) * | 2019-12-02 | 2020-01-31 | 山东汉泰生物科技有限公司 | Construction and application of acetaldehyde dehydrogenase gene engineering bacteria |
CN111471660A (en) * | 2020-03-12 | 2020-07-31 | 广州辉园苑医药科技有限公司 | Acetaldehyde dehydrogenase recombinant gene, lactobacillus vector and application thereof |
CN111494554A (en) * | 2019-01-31 | 2020-08-07 | 姜辉 | Dendrobium wine and preparation method of dendrobium anti-alcohol liquid |
-
2020
- 2020-09-07 CN CN202010925634.3A patent/CN111808877A/en active Pending
Patent Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102178937A (en) * | 2011-04-27 | 2011-09-14 | 珠海市御品堂生物科技有限公司 | Pharmaceutical composition for protecting liver and benefiting spleen and preparation method thereof |
CN103143003A (en) * | 2013-03-22 | 2013-06-12 | 武汉工程大学 | Healthcare product for relieving hangover and protecting liver |
WO2019140479A1 (en) * | 2018-01-19 | 2019-07-25 | Clever Health Pty Ltd | Compositions and methods for the prophylaxis or treatment of a condition associated with alcohol consumption |
CN110123952A (en) * | 2018-02-08 | 2019-08-16 | 深圳波顿香料有限公司 | A kind of anti-alcoholism liver protecting compound preparation and its application |
CN108103081A (en) * | 2018-02-13 | 2018-06-01 | 淄博职业学院 | A kind of acetaldehyde dehydrogenase and its application in terms of alcohol-neutralize healthy product |
WO2019209123A1 (en) * | 2018-04-27 | 2019-10-31 | Remedius Biotech Limited | Diagnosis, risk reduction and treatment of conditions associated with elevated aldehyde levels |
CN110432418A (en) * | 2018-05-05 | 2019-11-12 | 陈泂杉 | A kind of production method of liver-protecting and alcoholism-relieving drink |
CN109329941A (en) * | 2018-12-19 | 2019-02-15 | 九仙尊霍山石斛股份有限公司 | A kind of Dendrobidium huoshanness relieves the effect of alcohol particle and preparation method thereof |
CN111494554A (en) * | 2019-01-31 | 2020-08-07 | 姜辉 | Dendrobium wine and preparation method of dendrobium anti-alcohol liquid |
CN110101849A (en) * | 2019-04-12 | 2019-08-09 | 暨南大学 | A kind of composition and the preparation method and application thereof of enzymatic antialcoholism action |
CN110269166A (en) * | 2019-07-04 | 2019-09-24 | 北京九前健康科技有限公司 | A kind of preparation method of relieving alcoholism and protecting liver composition and drink and drink |
CN110734890A (en) * | 2019-12-02 | 2020-01-31 | 山东汉泰生物科技有限公司 | Construction and application of acetaldehyde dehydrogenase gene engineering bacteria |
CN111471660A (en) * | 2020-03-12 | 2020-07-31 | 广州辉园苑医药科技有限公司 | Acetaldehyde dehydrogenase recombinant gene, lactobacillus vector and application thereof |
Non-Patent Citations (6)
Title |
---|
MASAKO YOKOYAMA等: "Hangover susceptibility in relation to aldehyde dehydrogenase-2 genotype, alcohol flushing, and mean corpuscular volume in Japanese workers", 《ALCOHOL CLIN EXP RES》 * |
宋金波编著: "《历代实用药方经典》", 30 November 2017, 武汉:湖北科学技术出版社 * |
张传丽等: "乙醛脱氢酶基因表达载体的构建及表达条件筛选", 《江苏农业科学》 * |
王恒禹等: "葛根的解酒作用及应用", 《中国医疗前沿》 * |
郭建鹏等: "急性酒精中毒的中医论治及方药研究", 《中医药学报》 * |
陶施民等: "葛根枳椇子栀子胶囊解酒护肝功效研究", 《中医药导报》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104351586A (en) | Cattle mixed feed and preparation method thereof | |
CN108686011B (en) | Chicken's gizzard-membrane hawthorn granules for helping digestion of children and preparation method thereof | |
CN107854634A (en) | A kind of fermented tcm composition for treating gout and hyperuricemia | |
CN105395948A (en) | traditional Chinese medicine additive for eel and preparation method thereof | |
CN105851328A (en) | Uyghur blended fragrant tea drink and making process thereof | |
CN108686026B (en) | Licorice root and platycodon root granules for lung heat cough and preparation method thereof | |
CN105707888A (en) | Nutritious oatmeal capable of clearing away heat and toxic materials and preparation method thereof | |
CN102488744A (en) | Medicament for relieving alcohol toxicity and preparation method thereof | |
CN111808877A (en) | Production method, composition and preparation of acetaldehyde dehydrogenase | |
CN107823293A (en) | Treat Yao nationality medicine external pulvis of canker sore and preparation method thereof | |
CN101112453A (en) | Chinese traditional medicine composition for treating bacchia | |
KR101058422B1 (en) | Herbal dietary supplement and its manufacturing method | |
CN105995711A (en) | Fructus phyllanthi compound preparation and preparation method thereof | |
CN1284848C (en) | Dry red persimmon wine and its brewing method | |
CN110787268A (en) | Plant extract for improving intestinal digestion function and preparation method thereof | |
CN114869953B (en) | Composition for resisting fatigue and enhancing immunity and treating rheumatism and preparation method thereof | |
CN107582829A (en) | A kind of functional food of cancer-resisting | |
CN105795385A (en) | Fruit source nutrition based probiotics oral agent and preparation method thereof | |
CN105561192A (en) | Cordyceps sinensis and fructus hippophae healthy medicinal liquor | |
CN111700979A (en) | Chinese medicinal composition for treating drug addiction and application thereof | |
CN104888172B (en) | Treat ginger green onion cough arresting and the application of allergic cough | |
CN114404517A (en) | Composition for gout and reducing uric acid and application and preparation method thereof | |
CN117586846A (en) | Schisandra fruit vinegar and application thereof | |
CN117965258A (en) | Composite probiotics fermented glutinous rice and preparation method thereof | |
CN111543523A (en) | Inonotus obliquus health tea capable of nourishing yin, promoting production of body fluid and moistening lung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |